Chaitan Khosla is Professor of Chemical Engineering, Chemistry and Biochemistry at Stanford University. Khosla received his B. Tech from the Indian Institute of Technology, his Ph.D. from the California Institute of Technology and he was a post-doctoral fellow at the John Innes Centre in the U.K.
Khosla’s research interests bring together the fields of chemistry and medicine. His lab uses assembly line polyketide synthases as a system to investigate the potential to program biosynthetic pathways to produce new and different antibiotics. Another area of research in Khosla’s lab focuses on understanding the molecular underpinnings of celiac disease. Specifically the possibility that transglutaminase2, the main autoantigen in celiac disease, may be a target for drug development.
Khosla’s work has been recognized with numerous awards and honors including election to the American Academy of Arts and Sciences and the National Academy of Engineering.
